6-Bromo-3-(2-methylpropyl)-2-sulfanyl-3,4-dihydroquinazolin-4-one

Catalog No. :
ACABBZ028
CAS No. :
795290-90-3
Molecular Formula :
C12H13BrN2OS
Molecular Weight :
313.22

IUPAC Name:6-bromo-3-isobutyl-2-mercaptoquinazolin-4(3H)-one

6-Bromo-3-(2-methylpropyl)-2-sulfanyl-3,4-dihydroquinazolin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00Login to see priceInquiryInquiry
100mg95%$100.00Login to see priceInquiryInquiry
250mg95%$132.00Login to see priceInquiryInquiry
1g95%$337.00Login to see priceInquiryInquiry
5g95%$946.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-3-(2-methylpropyl)-2-sulfanyl-3,4-dihydroquinazolin-4-one
IUPAC Name6-bromo-3-isobutyl-2-mercaptoquinazolin-4(3H)-one
MDL No.MFCD06368753
Molecular FormulaC12H13BrN2OS
Molecular Weight313.22
SMILESO=C1N(CC(C)C)C(S)=NC2=C1C=C(Br)C=C2
InChI KeyVFDIUJNDINPEOS-UHFFFAOYSA-N
Synonym6-bromo-3-(2-methylpropyl)-2-sulfanylidene-1H-quinazolin-4-one;6-Bromo-3-isobutyl-2-thioxo-2,3-dihydroquinazolin-4(1H)-one;6-Bromo-3-(2-methylpropyl)-2-sulfanyl-3,4-dihydroquinazolin-4-one
CAS No.795290-90-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACABBZ028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACABBZ028 route product structure diagram
    ACABBZ028795290-90-3
Inquiry

2. ACABBZ028 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACABBZ028 route product structure diagram
    ACABBZ028795290-90-3
Inquiry

Comments (0)